Literature DB >> 426504

Methicillin potentiates the effect of gentamicin on methicillin-resistant Staphylococcus aureus.

R J Hemmer, P Vaudaux, F A Waldvogel.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) strains show an unusual type of resistance at 37 degrees C; only a small subpopulation of cells is resistant to the beta-lactam antibiotics. Incubation in the presence of methicillin (MET), however, results in the emergence of a homogenous population highly resistant to MET. The purpose of the present study was to determine whether MET, despite its lack of killing effect on MRSA, would promote the bactericidal effect of gentamicin (GM), as demonstrated for MET-susceptible strains of S. aureus. Eleven epidemiologically distinct strains of MRSA were incubated with MET at various concentrations, in the presence or absence of sub-bactericidal concentrations (1/5 or 1/10 of the minimal bactericidal concentration) of GM, and tested for the synergistic action of both antibiotics by three different methods. Population analysis of the 11 strains in the presence of high concentrations of MET showed that the addition of GM at 1/5 or 1/10 of its minimal bactericidal concentration resulted in marked killing of the 11 strains. Time-kill curves obtained with 32 mug of MET per ml and GM at 1/5 or 1/10 of its minimal bactericidal concentration confirmed this synergistic killing at 24 h. These results were further documented by the checkerboard method on two strains. We conclude that the synergism between MET and GM, previously demonstrated for MET-susceptible S. aureus, holds true for MRSA as well and that it can be demonstrated at sub-bactericidal concentrations of GM.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 426504      PMCID: PMC352596          DOI: 10.1128/AAC.15.1.34

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  CHARACTERISTICS OF METHICILLIN-RESISTANT STAPHYLOCOCCI.

Authors:  R SUTHERLAND; G N ROLINSON
Journal:  J Bacteriol       Date:  1964-04       Impact factor: 3.490

2.  [Serological study of 559 strains of pathogenic staphylococci isolated in France. Distribution and relative incidence of the different types].

Authors:  J PILLET; B ORTA; M FOUCAUD; M PERRIER
Journal:  Ann Inst Pasteur (Paris)       Date:  1961-06

3.  Enhancement of antistaphylococcal activity of nafcillin and oxacillin by sisomicin and netilmicin.

Authors:  C Watanakunakorn; C Glotzbecker
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

4.  Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals.

Authors:  D M Musher; R E Baughn; G B Templeton; J N Minuth
Journal:  J Infect Dis       Date:  1977-09       Impact factor: 5.226

5.  Detection of methicillin resistance in cultures of Staphylococcus aureus.

Authors:  D I Annear
Journal:  Lancet       Date:  1970-07-04       Impact factor: 79.321

6.  Methicillin resistance in Staphylococcus aureus.

Authors:  M T Parker; J H Hewitt
Journal:  Lancet       Date:  1970-04-18       Impact factor: 79.321

7.  Cell walls of methicillin-resistant Staphylococcus aureus.

Authors:  L D Sabath; C D Leaf; D A Gerstein; M Finland
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

8.  Interaction of neomycin with ribosomes and ribosomal ribonucleic acid.

Authors:  A E Dahlberg; F Horodyski; P Keller
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

9.  Selection and characterization of strains of Staphylococcus aureus displaying unusual resistance to aminoglycosides.

Authors:  S G Wilson; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

10.  RESISTANCE OF COAGULASE-POSITIVE STAPHYLOCOCCI TO METHICILLIN AND OXACILLIN.

Authors:  C F GRAVENKEMPER; J L BRODIE; W M KIRBY
Journal:  J Bacteriol       Date:  1965-04       Impact factor: 3.490

View more
  2 in total

Review 1.  Past and Present Perspectives on β-Lactamases.

Authors:  Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 2.  β-Lactams and β-Lactamase Inhibitors: An Overview.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.